IMNM insider transaction filings
Immunome Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-12. Screen IMNM transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-12 | 4 | Barchas Isaac — Director | Sale (S): 10,125 @ $26.07 · Sale (S): 62,291 @ $26.23 · Sale (S): 11,048 @ $27.25 | EDGAR |
| 2026-08-10 | 4 | Barchas Isaac — Director | Sale (S): 20,840 @ $26.06 · Sale (S): 15,248 @ $26.06 | EDGAR |
| 2026-08-06 | 4 | Horn Kinney — CHIEF BUSINESS OFFICER | Option exercise (M): 50,366 @ $12.92 · Option exercise (M): 40,250 @ $10.60 · Sale (S): 90,616 @ $25.09 · Option exercise (M): 50,366 (derivative) @ $0 · Option exercise (M): 40,250 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | SIEGALL CLAY B — President and CEO, Director | Grant/award (A): 180,000 @ $0 · Grant/award (A): 360,000 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | Lechleider Robert — Chief Medical Officer | Grant/award (A): 54,000 @ $0 · Grant/award (A): 108,000 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | Rosett Max — Chief Financial Officer | Grant/award (A): 47,250 @ $0 · Grant/award (A): 94,500 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | Higgins Jack — Chief Scientific Officer | Grant/award (A): 38,250 @ $0 · Grant/award (A): 76,500 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | Stoneman Sandra G. — CHIEF LEGAL OFFICER & GC | Grant/award (A): 38,250 @ $0 · Grant/award (A): 76,500 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | Tsai Philip — Chief Technical Officer | Grant/award (A): 38,250 @ $0 · Grant/award (A): 76,500 (derivative) @ $0 | EDGAR |
| 2026-07-27 | 4 | Horn Kinney — CHIEF BUSINESS OFFICER | Grant/award (A): 31,250 @ $0 · Grant/award (A): 62,500 (derivative) @ $0 | EDGAR |
| 2026-07-09 | 4 | Horn Kinney — CHIEF BUSINESS OFFICER | Option exercise (M): 1,092 @ $12.92 · Sale (S): 1,092 @ $25 · Option exercise (M): 1,092 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | Lechleider Robert — Chief Medical Officer | Option exercise (M): 55,000 @ $8.73 · Sale (S): 22,714 @ $21.95 · Sale (S): 16,214 @ $22.76 · Sale (S): 16,072 @ $23.44 · Option exercise (M): 55,000 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | Barchas Isaac — Director | Sale (S): 83,094 @ $24.11 · Sale (S): 16,906 @ $24.20 | EDGAR |
| 2026-07-02 | 4 | Barchas Isaac — Director | Sale (S): 101,050 @ $21.12 · Sale (S): 75,665 @ $22.35 · Sale (S): 24,335 @ $23.33 | EDGAR |
| 2026-06-29 | 4 | Lechleider Robert — Chief Medical Officer | Option exercise (M): 55,000 @ $8.73 · Sale (S): 40,580 @ $19.56 · Sale (S): 14,420 @ $20.66 · Option exercise (M): 55,000 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Rosett Max — Chief Financial Officer | Option exercise (M): 60,000 @ $1.05 · Sale (S): 60,000 @ $18.23 · Option exercise (M): 60,000 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Boylan James P — Director | Grant/award (A): 9,897 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | SWAIN SANDRA M — Director | Grant/award (A): 9,897 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Barchas Isaac — Director | Grant/award (A): 9,897 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | WAGENHEIM PHILIP — Director | Grant/award (A): 9,897 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | SCHAFER CAROL — Director | Grant/award (A): 9,897 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | BIENAIME JEAN JACQUES — Director | Grant/award (A): 9,897 (derivative) @ $0 | EDGAR |
| 2026-06-09 | 4 | BIENAIME JEAN JACQUES — Director | Sale (S): 500 @ $19.44 · Sale (S): 10,000 @ $19.41 · Purchase (P): 6,000 @ $19.48 · Purchase (P): 3,500 @ $19.46 · Purchase (P): 1,000 @ $19.27 | EDGAR |
| 2026-05-19 | 4 | BIENAIME JEAN JACQUES — Director | Purchase (P): 5,000 @ $20.70 | EDGAR |
| 2026-04-03 | 4 | Rosett Max — Chief Financial Officer | Option exercise (M): 31,848 @ $1.05 · Option exercise (M): 39,713 @ $1.35 · Sale (S): 63,656 @ $21.91 · Sale (S): 1,344 @ $22.48 · Option exercise (M): 31,848 (derivative) @ $0 · Option exercise (M): 39,713 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Higgins Jack — Chief Scientific Officer | Sale (S): 9,438 @ $21.64 | EDGAR |
| 2026-04-01 | 4 | Higgins Jack — Chief Scientific Officer | Gift (G): 6,291 @ $0 | EDGAR |
| 2026-03-31 | 4 | SIEGALL CLAY B — President and CEO, Director | Purchase (P): 25,450 @ $19.67 | EDGAR |
| 2026-03-23 | 4 | WAGENHEIM PHILIP — Director | Sale (S): 36,800 @ $20.47 · Sale (S): 28,200 @ $20.65 | EDGAR |
| 2026-03-12 | 4 | BIENAIME JEAN JACQUES — Director | Purchase (P): 1,000 @ $22.12 · Purchase (P): 1,000 @ $21.55 | EDGAR |
| 2025-12-30 | 4 | SIEGALL CLAY B — President and CEO, Director | Purchase (P): 4,729 @ $21.15 | EDGAR |
| 2025-12-23 | 4 | Barchas Isaac — Director | Sale (S): 371,949 @ $21.72 · Sale (S): 11,251 @ $22.34 | EDGAR |
| 2025-12-22 | 4 | Tsai Philip — Chief Technical Officer | Purchase (P): 10,000 @ $20.49 | EDGAR |
| 2025-12-22 | 4 | Higgins Jack — Chief Scientific Officer | Gift (G): 1,000 @ $0 · Gift (G): 1,000 @ $0 · Gift (G): 1,000 @ $0 · Gift (G): 1,000 @ $0 · Gift (G): 1,000 @ $0 · Gift (G): 1,000 @ $0 | EDGAR |
| 2025-12-22 | 4 | SIEGALL CLAY B — President and CEO, Director | Purchase (P): 7,278 @ $20.48 · Gift (G): 200,000 @ $0 | EDGAR |
| 2025-12-18 | 4 | SIEGALL CLAY B — President and CEO, Director | Purchase (P): 46,511 @ $21.50 | EDGAR |
| 2025-09-11 | 4 | Higgins Jack — Chief Scientific Officer | Option exercise (M): 22,000 @ $1.35 · Option exercise (M): 22,000 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Tsai Philip — Chief Technical Officer | Grant/award (A): 190,000 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Rosett Max — Chief Financial Officer | Grant/award (A): 207,000 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Lechleider Robert — Chief Medical Officer | Grant/award (A): 242,000 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Horn Kinney — CHIEF BUSINESS OFFICER | Grant/award (A): 161,000 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Higgins Jack — Chief Scientific Officer | Grant/award (A): 196,000 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Stoneman Sandra G. — CHIEF LEGAL OFFICER & GC | Grant/award (A): 190,000 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | SIEGALL CLAY B — President and CEO, Director | Grant/award (A): 800,000 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Boylan James P — Director | Grant/award (A): 18,864 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Barchas Isaac — Director | Grant/award (A): 18,864 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | SWAIN SANDRA M — Director | Grant/award (A): 18,864 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | WAGENHEIM PHILIP — Director | Grant/award (A): 18,864 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | SCHAFER CAROL — Director | Grant/award (A): 18,864 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | BIENAIME JEAN JACQUES — Director | Grant/award (A): 18,864 (derivative) @ $0 | EDGAR |
Recent 8-K events — Immunome Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-12 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-03 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-17 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-15 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-06-11 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2025-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=IMNM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →